05/25
Headlines

DRTX

Biotech New Highs: BioSpecifics Technologies (NASDAQ:BSTC), Five Prime Therapeutics (NASDAQ:FPRX), IGI Laboratories (NYSEMKT:IG), Durata Therapeutics (NASDAQ:DRTX)

Colin Pettis02 mins

BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications. BioSpecifics Technologies Corp. (NASDAQ:BSTC) stock performance was 2.14% in last session and finished the day at $27.16. Traded volume was 61,391.00 shares in the last session and the average volume of the stock remained 27,510.00 shares….

Read More

Eye Catching Stocks: Arch Coal Inc. (NYSE:ACI), Zynga Inc (NASDAQ:ZNGA), Microvision Inc. (NASDAQ:MVIS), Durata Therapeutics, Inc. (NASDAQ:DRTX), Territorial Bancorp Inc. (NASDAQ:TBNK)

Chris Lewis03 mins

Arch Coal Inc., (NYSE:ACI) a producer of the commodity in Appalachia and the western United States, rose the most in more than two months after reporting an increase in cash on hand and profit that beat analysts’ estimates. The company also said it had $1.05 billion of cash and short-term investments as of Sept. 30,…

Read More

Stock Runners: Repligen (NASDAQ:RGEN), Durata Therapeutics (NASDAQ:DRTX), Acadia Realty Trust (NYSE:AKR), International Game Technology (NYSE:IGT), DDR Corp. (NYSE:DDR)

Chris Lewis03 mins

Repligen Corp. (NASDAQ:RGEN) released its earnings data on Monday, 11 Aug 2014. The company reported $0.09 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.06 by $0.03. The company had revenue of $15.60 million for the quarter, compared to the consensus estimate of $14.90 million. During the same quarter in the prior…

Read More